Effective pharmacotherapy, carefully selected supplementation and AI-powered clinical support - in one physician-supervised program.
Take the first step. We will handle the rest.
Start the program →Each patient receives an individually designed treatment plan based on laboratory results and medical history - under physician supervision and supported by AI (Artificial Intelligence) analytical tools.
A clinical program that combines pharmacotherapy with real support
at every stage of treatment
AI Weight Loss Program is not another diet or a supplement shortcut. It is a structured medical protocol combining tirzepatide pharmacotherapy, carefully selected supplementation and regular physician supervision. Together, they create an environment in which sustainable and measurable weight loss becomes achievable - safely and under full specialist control.
Supplementation tailored to therapy
A set of nutrients supporting mineral and vitamin balance. No unnecessary extras — only what your body truly needs.
Mounjaro® - Obesity Pharmacotherapy
Tirzepatide - a dual GIP and GLP-1 receptor agonist. An approved medication for overweight and obesity treatment, demonstrating exceptionally high efficacy in clinical studies. Introduced exclusively by physicians within full clinical supervision.
Analytical Support and Monitoring
Analytical tools help the physician track your results, detect the need for adjustments and refine the protocol. The physician makes the decisions — technology is the tool.
Significant weight reduction
A protocol based on pharmacotherapy with proven clinical efficacy - not short-term restrictions.
Lower risk of weight regain
The consolidation phase at the end of the program helps the body maintain the achieved weight.
Improved cardiometabolic parameters
Tirzepatide has shown beneficial effects on glucose levels, lipid profile and blood pressure.
Individual treatment plan
The therapy takes into account test results, medical history and lifestyle — the physician adjusts the plan with AI-supported analysis.
Clear reduction in hunger and appetite
Tirzepatide acts directly on appetite regulation mechanisms — making lifestyle changes easier to maintain.
Full clinical safety
Every stage is supervised by a specialist physician with regular laboratory monitoring.
Your results are analyzed.
The physician responds to changes and makes adjustments.
Mounjaro® - tirzepatide
A new generation of obesity treatment
Tirzepatide acts simultaneously on two incretin receptors: GIP and GLP-1. The result is effective appetite control, rapid weight reduction and a beneficial impact on metabolic profile.
Initial diagnostics
You complete an online medical questionnaire. AI-supported analysis and the physician review your answers and determine eligibility for the program.
Individual treatment plan
The physician and AI-supported analysis create a personalized pharmacological and supplementation protocol.
Implementation and monitoring
Dose setup, initiation of supplementation, regular data analysis and continuous review of results.
Consolidation and maintenance
The physician adjusts the protocol. The consolidation phase reinforces habits and minimizes the risk of relapse.
Obesity is a chronic disease — not a matter of willpower. AI Weight Loss Program gives the patient tools appropriate to the complexity of this challenge: effective pharmacotherapy, tailored supplementation and regular monitoring within one clinical protocol supported by AI (Artificial Intelligence).
Clinical opinion of AI Weight Loss Program specialists
Your path to real change
in 4 steps
AI Weight Loss™ · Clinical Program